Negative Side Effects of Ambien (Zolpidem)
Ambien carries serious risks including complex sleep behaviors (sleep-driving, sleep-walking), falls and fractures, cognitive impairment, and increased mortality, with particularly high risks in older adults and those with substance abuse history who should generally avoid this medication. 1, 2
Most Serious and Life-Threatening Adverse Effects
Complex Sleep Behaviors
- Sleep-driving, sleep-walking, and engaging in activities while not fully awake can occur after the first or any subsequent dose, potentially resulting in serious injury or death. 1
- Other complex behaviors include preparing food, making phone calls, or having sex without memory of these events. 1
- These behaviors can occur at recommended doses, even without alcohol or other CNS depressants. 1
- The FDA mandates immediate discontinuation if complex sleep behaviors occur. 1
Falls, Fractures, and Physical Injuries
- Zolpidem increases fracture risk with an adjusted odds ratio of 1.72 (95% CI 1.37-2.16). 2
- Hip fractures specifically show a relative risk of 1.92 (95% CI 1.65-2.24). 3
- Major head injuries or fractures requiring hospitalization have an adjusted hazard ratio of 1.67 (95% CI 1.19-2.34). 2
- Hospitalized patients face a 4.28-fold increased risk of falls (P <0.001). 3
Cognitive and Psychiatric Effects
- Memory impairment, psychiatric adverse events, depression, and anxiety occur at higher rates with long-term use according to FDA medical reviews. 4
- Older patients experience a 5-fold increase in memory loss, confusion, and disorientation compared to placebo. 2, 4
- A 3-fold increase in dizziness, loss of balance, or falls occurs in elderly patients. 2, 4
- Hallucinations were reported in 7% of pediatric patients (versus 0% with placebo). 1
Mortality and Cancer Risk
- Anxiolytic and hypnotic drugs including zolpidem are associated with increased all-cause mortality in observational data from the UK General Practice Research Database. 2, 4
- Some studies show association with incident cancers, though evidence is inconsistent. 2
Common Adverse Effects
Next-Day Impairment
- The FDA specifically warns about impaired driving the morning after use, with women experiencing slower drug clearance and greater next-day impairment than men. 1
- Risk increases if taken with less than 7-8 hours of sleep remaining, at higher than recommended doses, or with other CNS depressants. 1
- Common CNS effects include drowsiness, prolonged reaction time, dizziness, sleepiness, blurred/double vision, and reduced alertness. 1
Dose-Dependent Effects
- Withdrawals due to adverse effects occur more frequently with zolpidem than placebo (6% versus 3%). 2
- In elderly patients, 80.8% of adverse drug reactions were CNS-related including confusion, dizziness, and daytime sleepiness. 3
High-Risk Populations Requiring Special Caution
Older Adults
- The American Geriatrics Society recommends avoiding benzodiazepine-like GABA receptor hypnotics including zolpidem in older adults due to sedation, cognitive impairment, and unsafe mobility with injurious falls. 2, 4
- The recommended dose in elderly patients is 5 mg (not 10 mg) to minimize adverse effects. 1
- In non-U.S. trials, 93% of patients reporting falls were ≥70 years old, with 82% taking doses >10 mg. 1
Women
- Women clear zolpidem 45% slower than men, resulting in higher blood levels and greater risk of next-day impairment. 1
- The FDA-recommended initial dose for women is 5 mg (versus 5-10 mg for men). 1
- Women had higher mean plasma concentrations than men after 8 hours (28 vs. 20 ng/mL for 10mg IR). 3
Patients with Substance Abuse History
- Zolpidem can lead to tolerance, abuse, and dependence despite initial claims of low abuse potential. 5
- Withdrawal seizures have been reported, occurring at daily dosages as low as 160 mg/day but more commonly at 450-600 mg/day. 3, 5
- One case report documented a patient escalating from normal dosing to 450 mg/day over five years, developing tolerance, abuse, dependence, and withdrawal seizures. 5
Pregnant and Breastfeeding Women
- Limited postmarketing reports describe severe to moderate respiratory depression in neonates requiring artificial ventilation or intubation. 1
- Increased incidence of low birth weight (OR 1.39), preterm delivery (OR 1.49), small for gestational age babies (OR 1.34), and cesarean deliveries (OR 1.74). 3
- Zolpidem is present in breast milk and can cause excess sedation, hypotonia, and respiratory depression in infants. 1
Patients with Depression
- Worsening of depression and suicidal thoughts/actions (including completed suicides) have been reported in depressed patients taking sedative-hypnotics. 1
- Suicide attempts and completion are significantly linked with zolpidem use (OR 2.08; 95% CI 1.83-2.63) regardless of comorbid psychiatric illness. 3
Tolerance and Withdrawal Effects
Loss of Efficacy
- Long-term trials show zolpidem was not statistically significantly different from placebo for sleep onset latency, total sleep time, or wake after sleep onset, indicating loss of efficacy with continued use. 4
Rebound Insomnia
- Sleep onset latency significantly increased on the first night after stopping zolpidem (13.0 minutes; 95% CI 4.3-21.7; P<0.01). 3
- However, most evidence suggests minimal rebound insomnia when used as recommended. 6, 7
Critical Prescribing Pitfalls to Avoid
- Never prescribe doses exceeding 10 mg in men or 5 mg in women due to increased risk of next-day impairment and complex sleep behaviors. 8, 1
- Avoid use in patients with severe hepatic impairment as it may contribute to encephalopathy. 1
- Do not combine with other CNS depressants (benzodiazepines, opioids, alcohol) without dosage adjustments due to additive effects. 1
- Zolpidem should only be used for short-term treatment (≤4 weeks) to minimize dependency and adverse effects. 8, 7
- If discontinuing after prolonged use, taper gradually rather than abrupt cessation to minimize withdrawal symptoms. 8
- Ensure patients have a full 7-8 hours available for sleep before taking zolpidem. 1